PhoenixBio Co (TSE:6190) Other Current Assets: 円51 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6190 PhoenixBio Co Ltd TSE:6190
51 GF Score
Price 円348.00
GF Value 円354.17
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PhoenixBio Co Other Current Assets?

PhoenixBio Co TSE:6190 +1.46% 51 Other Current Assets is 円51 Mil as of Mar. 2026. GuruFocus rates TSE:6190 with a GF Score™ of 51/100 and a GF Value™ of 円354.17 (Fairly Valued). The stock has 5 warning signs investors should review.

PhoenixBio Co's other current assets for the quarter that ended in Mar. 2026 was 円51 Mil.

PhoenixBio Co's quarterly other current assets declined from Sep. 2025 (円92 Mil) to Dec. 2025 (円66 Mil) and declined from Dec. 2025 (円66 Mil) to Mar. 2026 (円51Mil).

PhoenixBio Co's annual other current assets declined from Mar. 2024 (円79 Mil) to Mar. 2025 (円64 Mil) declined from Mar. 2025 (円64 Mil) to Mar. 2026 (円51 Mil).


PhoenixBio Co Other Current Assets Related Terms


PhoenixBio Co Other Current Assets Historical Data

* Premium members only.

The historical data trend for PhoenixBio Co's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhoenixBio Co Other Current Assets Chart

PhoenixBio Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.29 84.84 79.07 63.92 51.30

PhoenixBio Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.92 76.06 92.43 66.29 51.30
TSE:6190
51GF Score
PhoenixBio Co Ltd TSE:6190
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhoenixBio Co Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of 円51 Mil mean?
PhoenixBio Co (TSE:6190) has a Other Current Assets of 円51 Mil as of Mar. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on PhoenixBio Co.
Is PhoenixBio Co's Other Current Assets too high?
PhoenixBio Co's current Other Current Assets is 円51 Mil. Overall, PhoenixBio Co has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PhoenixBio Co's Other Current Assets compare to VRTX and REGN?
PhoenixBio Co's Other Current Assets of 円51 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Biotechnology company?
A good Other Current Assets depends on the Biotechnology industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on PhoenixBio Co. PhoenixBio Co's current Other Current Assets is 円51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhoenixBio Co stock overvalued right now?
Based on GuruFocus' analysis, PhoenixBio Co (TSE:6190) is currently considered Fairly Valued. The stock's GF Value™ is 円354.17, compared to a current price of 円348.00 — trading 1.7% below its estimated fair value. The current Other Current Assets is 円51 Mil. PhoenixBio Co's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For PhoenixBio Co (TSE:6190), the current Other Current Assets is 円51 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円348.00 is trading 1.7% below its estimated GF Value™ of 円354.17. GuruFocus considers PhoenixBio Co to be Fairly Valued.

Key valuation signals for TSE:6190:

  • Other Current Assets: 円51 Mil
  • GF Value™: 円354.17 vs. price of 円348.00 (1.7% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhoenixBio Co Business Description

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
51GF Score

Get the complete analysis for TSE:6190

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円348.00
Price
円354.17
GF Value